Difference between revisions of "Bioelectronic Devices for Electrical Stimulation"

From MIT Technology Roadmapping
Jump to navigation Jump to search
Tag: Manual revert
Line 44: Line 44:


==Financial Model==
==Financial Model==
==References==
XXX

Revision as of 02:31, 12 October 2023

Technology Roadmap Sections and Deliverables

The Bioelectronic Devices for Electrical Stimulation [3BDES] is a level 3 technology roadmap focused around electrically stimulating biological systems (e.g., muscles, nerves, cells) for clinical purposes. A roadmap will be developed to explore the current status of the technology and the potential venues of progress from both a technical and business side.

Roadmap Overview

Bioelectronic Medicine is a novel approach that combines molecular medicine, neuroscience, and bioengineering to threaten and diagnose diseases and injuries. Bioelectronic devices can read and modulate electrical activity within the body. These devices open new possibilities and alternatives to diagnose and treat real-time diseases by using electrical pulses to restore health instead of chemical and biological drugs. In the literature, Bioelectronic Medicine can be found as neuromodulation, biostimulation, or electroceuticals. 1 2 3


The bioelectronic devices that delivers electrical stimulation and dominate the market are: ​

  1. Implantable Cardioverter Defibrillators (ICD)​
  1. Cardiac Pacemakers (CP)​
  1. Cochlear Implants (CI)​
  1. Spinal Cord Stimulators (SCS)​
  1. Deep Brain Stimulators (DBS)​
  1. Sacral Nerve Stimulators (SNS)​
  1. Transcutaneous Electrical Nerve Stimulators (TENS)​
  1. Vagus Nerve Stimulators

Design Structure Matrix (DSM) Allocation

XXX

Roadmap Model using OPM

XXX

Figures of Merit

XXX

Alignment with Company Strategic Drivers

XXX

Positioning of Company vs. Competition

XXX

Technical Model

XXX

Financial Model

References

XXX